Tuesday, 17 November 2026 SEC EDGAR filings, as they land
ALFA USA News Straight from the SEC filing
SEC Filings

Aclaris Therapeutics, Inc. — Latest News

Every SEC filing by Aclaris Therapeutics, Inc. that we have reported, newest first. Each story links the original filing.

NASDAQ: ACRS · Biotechnology · 3 stories

Share price
$3.92
Market cap
$622M
Revenue (annual)
$8M

Reference market data from a third-party provider, as of the most recent story (16 Nov 2026). Not a valuation or a recommendation.

Aclaris Therapeutics, Inc. share price · last month
Line chart of Aclaris Therapeutics, Inc.'s share price over the last month, from $3.48 on 19 Oct → $3.60 on 16 Nov.

Up 3.6% over the last month ($3.48 on 19 Oct → $3.60 on 16 Nov). Daily closing prices. Source: Yahoo Finance.

Show the prices
19 Oct$3.48
20 Oct$3.77
21 Oct$3.81
22 Oct$3.83
23 Oct$3.75
26 Oct$3.79
27 Oct$3.79
28 Oct$3.96
29 Oct$3.99
30 Oct$3.97
2 Nov$3.80
3 Nov$3.74
4 Nov$3.68
5 Nov$3.61
6 Nov$3.90
9 Nov$4.24
10 Nov$4.15
11 Nov$4.34
12 Nov$4.00
13 Nov$3.92
16 Nov$3.60
Other 2Capital Raise 1

Track Aclaris Therapeutics, Inc. live

Get the next Aclaris Therapeutics, Inc. SEC filing seconds after it lands.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.